NovoCure Ltd
NVCR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001645113
No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by NovoCure Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for NovoCure Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Puri Michal Nath | Chief Human Resources Officer | 203,227 | Jul 1, 2026 | 4 |
| Leonard Frank X | Chief Executive Officer | 461,425 | Jul 1, 2026 | 5 |
| Ben Arye Barak | General Counsel | 243,752 | Jul 1, 2026 | 3 |
| Danziger Asaf | Director | 416,742 | Jul 1, 2026 | 1 |
| Hilleman Jeryl L | Director | 25,471 | Jun 5, 2026 | 2 |
| Leung Gabriel | Director | 101,109 | Jun 5, 2026 | 2 |
| Hung David | Director | 32,075 | Jun 5, 2026 | 2 |
| Vernon W Anthony | Director | 209,267 | Jun 5, 2026 | 3 |
| Scannell Timothy J | Director | 25,898 | Jun 5, 2026 | 2 |
| Madden Martin J. | Director | 30,284 | Jun 5, 2026 | 1 |
| Ocean Allyson J | Director | 22,934 | Jun 5, 2026 | 2 |
| Stafford Kristin | Director | 22,934 | Jun 5, 2026 | 2 |
| Doyle William F | Executive Chairman | 328,397 | Mar 5, 2026 | 1 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 267,190 | Mar 5, 2026 | 2 |
| Cordova Ashley | Former Chief Executive Officer | 422,570 | Mar 5, 2026 | 2 |
| Leupin Nicolas | Former Chief Medical Officer | 102,979 | Mar 5, 2026 | 2 |
| Paravasthu Mukund | Chief Operating Officer | 72,832 | Mar 5, 2026 | 4 |
| Brackmann Christoph | Chief Financial Officer | 182,842 | Mar 5, 2026 | 2 |
| Groenhuysen Wilhelmus CM | Chief Operating Officer | 252,290 | Aug 6, 2024 | 0 |
| Giladi Moshe | Chief Science Officer | 69,771 | Feb 29, 2024 | 0 |
| Shah Pritesh | Chief Growth Officer | 124,511 | Nov 8, 2023 | 0 |
| Burke William Patrick | Chief Human Resources Officer | 66,447 | Jul 6, 2023 | 0 |
| Benaim Ely | Chief Medical Officer | 28,770 | Jan 10, 2023 | 0 |
| Longsworth Todd Christopher | General Counsel | 62,462 | Mar 9, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Leonard Frank XChief Development Officer | SSale | −744 | $70.10 | −$52.2K | −0.7%102.3K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Burke William PatrickChief Human Resources Officer | SSale | −1.04K | $70.10 | −$72.7K | −1.8%56.0K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Groenhuysen Wilhelmus CMChief Operating Officer | SSale | −2.92K | $70.10 | −$204.9K | −1.7%165.1K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Cordova AshleyChief Financial Officer | SSale | −759 | $70.10 | −$53.2K | −1.2%60.8K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Longsworth Todd ChristopherGeneral Counsel | SSale | −2.34K | $70.10 | −$164.0K | −3.6%62.5K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Doyle William FExecutive Chairman | SSale | −2.38K | $70.10 | −$167.2K | −0.4%552.0K after | |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Longsworth Todd ChristopherGeneral Counsel | SSale | −3.07K | $71.87 | −$220.4K | −4.5%64.8K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Cordova AshleyChief Financial Officer | SSale | −1.71K | $73.17 | −$124.7K | −2.7%61.6K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Shah PriteshChief Commercial Officer | SSale | −5.54K | $72.54 | −$402.1K | −5.8%89.7K after | 3 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Benaim ElyChief Medical Officer | SSale | −2.31K | $71.83 | −$166.1K | −5.1%43.3K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Burke William PatrickChief Human Resources Officer | SSale | −1.37K | $71.43 | −$97.6K | −2.3%57.0K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Groenhuysen Wilhelmus CMChief Operating Officer | SSale | −3.87K | $71.78 | −$277.8K | −2.3%168.0K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Leonard Frank XChief Development Officer | SSale | −1.49K | $72.97 | −$108.4K | −1.4%103.0K after | 2 lots |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Burke William PatrickChief Human Resources Officer | SSale | −3.95K | $76.00 | −$300.3K | −7.2%50.9K after | 3 lots |
| Nov 29, 2021 (view filing) | Nov 26 | 3 days | Danziger AsafChief Executive Officer | PPurchase | +4.97K | $102.44 | +$509.5K | +59.9%13.3K after | 3 lots |
| Nov 3, 2021 (view filing) | Nov 2 | 1 day | Cordova AshleyChief Financial Officer | SSale | −209 | $107.28 | −$22.4K | −0.5%41.8K after | |
| Sep 7, 2021 (view filing) | Sep 2 | 5 days | Leonard Frank XChief Development Officer | SSale | −540 | $138.23 | −$74.6K | −0.6%87.2K after | |
| Sep 7, 2021 (view filing) | Sep 2 | 5 days | Cordova AshleyChief Financial Officer | SSale | −828 | $138.23 | −$114.5K | −1.9%42.0K after | |
| Sep 7, 2021 (view filing) | Sep 2 | 5 days | Groenhuysen Wilhelmus CMChief Operating Officer | SSale | −181 | $138.23 | −$25.0K | −0.1%149.9K after | |
| Sep 7, 2021 (view filing) | Sep 2-3 | 5 days | Shah PriteshChief Commercial Officer | SSale | −657 | $138.57 | −$91.0K | −0.9%73.5K after | 4 lots |
| Aug 16, 2021 (view filing) | Aug 12 | 4 days | Cordova AshleyChief Financial Officer | SSale | −26.6K | $140.94 | −$3.75M | −36.7%46.0K after | 5 lots |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Madden Martin J.Director | SSale | −34 | $153.13 | −$5.21K | −8.1%384 after | |
| Aug 6, 2021 (view filing) | Aug 4 | 2 days | Shah PriteshChief Commercial Officer | SSale | −2.06K | $148.71 | −$306.8K | −2.7%74.2K after | |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Leung GabrielDirector | SSale | −1.00K | $152.50 | −$152.5K | −1.4%72.9K after | |
| Aug 4, 2021 (view filing) | Aug 2-3 | 2 days | Leonard Frank XChief Development Officer | SSale | −1.04K | $149.40 | −$155.5K | −1.2%89.2K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Shah PriteshChief Commercial Officer | SSale | −1.65K | $149.43 | −$247.2K | −2.1%76.2K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Doyle William FExecutive Chairman | SSale | −995 | $149.38 | −$148.6K | −0.2%554.4K after | |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Benaim ElyChief Medical Officer | SSale | −464 | $150.11 | −$69.7K | −1.6%28.1K after | |
| Aug 3, 2021 (view filing) | Jul 30-Aug 2 | 4 days | Benaim ElyChief Medical Officer | SSale | −1.19K | $154.63 | −$183.6K | −4.0%28.6K after | 2 lots |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Leung GabrielDirector | SSale | −1.00K | $183.54 | −$183.5K | −1.4%72.9K after |